Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
Michele Fornaro,1,2 Marco Solmi,3–5 Giampaolo Perna,2,6 Domenico De Berardis,2,7 Nicola Veronese,5,8 Laura Orsolini,2,9 Licinia Ganança,1,10 Brendon Stubbs11,12 1New York State Psychiatric Institute, Columbia University, New York City, NY, USA; 2Polyedra Research Group®...
Enregistré dans:
Auteurs principaux: | Fornaro M, Solmi M, Perna G, De Berardis D, Veronese N, Orsolini L, Ganança L, Stubbs B |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2016
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/01b547c7a5a14b5b9dc87b7a7909db7e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
par: Guerdjikova AI, et autres
Publié: (2016) -
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies
par: Citrome L, et autres
Publié: (2018) -
Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges
par: Chevinsky JD, et autres
Publié: (2020) -
Impact of Bariatric Surgery on the Healthy Eating Index, Binge Eating Behavior and Food Craving in a Middle Eastern Population: A Lebanese Experience
par: Jana Jabbour, et autres
Publié: (2021) -
Prevalence of Binge-Eating Disorder and Its Association with Nicotine Dependence Among Under-Graduate Students at a Saudi Public University
par: Bin Abdulrahman KA, et autres
Publié: (2021)